Regression of a Large Malignant Gastrinoma on Treatment with Sandostatin LAR®: A Case Report

Publisher： Karger

E-ISSN： 1421-9867|77|2|92-95

ISSN： 0012-2823

Source： Digestion, Vol.77, Iss.2, 2008-03, pp. : 92-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical experience with Sandostatin LAR ( R) in patients with acromegaly

By Heijckmann C.A. Menheere P.P.C.A. Sels J.-P.J.E. Beuls E.A.M. Wolffenbuttel B.H.R.

The Netherlands Journal of Medicine, Vol. 59, Iss. 6, 2001-12 ,pp. : 286-291

Elsevier

Access to resources Recommend Favorite

CASE REPORT: Laparoscopic Radiofrequency Ablation of Solitary Hepatic Gastrinoma Metastases

By Frezza Eldo Ermenegildo

Digestive Diseases and Sciences, Vol. 49, Iss. 2, 2004-02 ,pp. : 224-227

Springer Publishing Company

Access to resources Recommend Favorite

Study of a Primary Gastrinoma in the Common Hepatic Duct – A Case Report

Digestion, Vol. 60, Iss. 2, 1999-03 ,pp. : 187-190

Karger

Access to resources Recommend Favorite

Effects of Sandostatin LAR on gastrointestinal motility in patients with neuroendocrine tumors

By Gregersen Tine Grøønbææk Henning Worsøøe Jonas Schlageter Vincent Laurberg Søøren Krogh Klaus

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 7-8, 2011-07 ,pp. : 895-902

Informa Healthcare

Access to resources Recommend Favorite

Sandostatin^® LAR^® Leaders Meeting – European Neuroendocrine Tumour Network ENET

Digestion, Vol. 62, Iss. 1, 2000-07 ,pp. : 98-107

Karger

Access to resources Recommend Favorite